GMP Ready Offerings Teknova offers customizable reagents and a modular manufacturing platform that scales from RUO to GMP, supporting cell and gene therapy, molecular diagnostics, and synthetic biology—prime for selling GMP-grade materials and transition services.

Scale Ready Capacity With over 200,000 square feet of facilities and a scalable platform, Teknova can rapidly increase production, enabling longer-term, high-volume supply agreements as customers move from research to clinical development.

Clinical Growth Momentum Growing clinical customer counts and positive revenue momentum, including a 13% Q1 2026 revenue rise and 2026 guidance of $42–$44 million, indicate a healthy pipeline of clinical-stage buyers for expanded reagent portfolios.

Cross-Segment Opportunities Teknova serves multiple high-growth segments—cell and gene therapy, vaccines, molecular diagnostics, and synthetic biology—creating cross-sell opportunities for both RUO and GMP reagents, plus core lab consumables like media, buffers, and water.

Strategic Partnerships The combination of scale, customization, and ongoing revenue growth makes Teknova a strong candidate for strategic partnerships, preferred supplier agreements, or co-development opportunities with biotech, pharma, and contract manufacturers.